Gyre Therapeutics (GYRE) Earnings Date & Reports

Gyre Therapeutics Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of small-molecule therapies for the treatment of organ fibrosis and inflammatory diseases... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

GYRE is expected to report earnings to fall 38.92% to -7 cents per share on November 18

Gyre Therapeutics GYRE Stock Earnings Reports

Q3'26

Est.

$-0.07

Q2'26

Missed

by $0.06

Q1'26

Missed

by $0.03

Q4'25

Missed

by $0.07

Q3'25

Missed

by $0.02

The last earnings report on August 07 showed earnings per share of -11 cents, missing the estimate of -5 cents. With 66.90K shares outstanding, the current market capitalization sits at 779.35M.

View a ticker or compare two or three

GYRE

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

View AI-Driven Trading for GYRE